8305C
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1053
|
Homo sapiens (Human)
|
Thyroid gland anaplastic carcinoma
|
Population: Japanese., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9177455
PMID:9290701
PMID:14522906
PMID:15613457
PMID:16924234
PMID:20164919
PMID:21566963
PMID:22460905
PMID:23833040
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30737244
PMID:30894373
PMID:31068700
PMID:31395879
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Female |
8305c, 8305-C, 8305C_1 |
|
|
BTO:BTO_0000919,
CLO:CLO_0001510,
CLO:CLO_0050949,
EFO:EFO_0022717,
CLDB:cl132,
CLDB:cl133,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:318,
BioSample:SAMN01821670,
BioSample:SAMN03470959,
BioSample:SAMN03473414,
BioSample:SAMN10988447,
cancercelllines:CVCL_1053,
CCRID:3101HUMSCSP540,
Cell_Model_Passport:SIDM00997,
CGH-DB:53-1,
ChEMBL-Cells:CHEMBL3308706,
ChEMBL-Targets:CHEMBL1075386,
CLS:305101,
Cosmic:906795,
Cosmic:922364,
Cosmic:2009523,
Cosmic:2054104,
Cosmic:2613247,
Cosmic:2786687,
Cosmic-CLP:906795,
DepMap:ACH-001306,
DSMZ:ACC-133,
DSMZCellDive:ACC-133,
ECACC:94090183,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10428-106D5,
GDSC:906795,
GEO:GSM886846,
GEO:GSM887910,
GEO:GSM1669573,
IARC_TP53:21156,
ICLC:HTL96026,
JCRB:JCRB0824,
LiGeA:CCLE_684,
LINCS_LDP:LCL-1685,
NCBI_Iran:C597,
PharmacoDB:8305C_30_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1053,
PubChem_Cell_line:CVCL_1053,
RCB:RCB1909,
TKG:TKG 0446,
Wikidata:Q54605326 |
|
|
CVCL_1053 |
2026-09-05 11:43:43 |
6 |
42-MG-BA
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1798
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9604998
PMID:22460905
PMID:26589293
PMID:27397505
PMID:28464039
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
42MGBA |
|
|
CLO:CLO_0001367,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:440,
BioSample:SAMN03473596,
BioSample:SAMN10988275,
cancercelllines:CVCL_1798,
Cell_Model_Passport:SIDM00982,
Cosmic:687561,
Cosmic:1746946,
Cosmic:1995325,
Cosmic:2060804,
Cosmic:2302328,
Cosmic:2732518,
Cosmic-CLP:687561,
DepMap:ACH-000323,
DSMZ:ACC-431,
DSMZCellDive:ACC-431,
EGA:EGAS00001000978,
GDSC:687561,
GEO:GSM326214,
GEO:GSM886839,
GEO:GSM887902,
GEO:GSM1669567,
IARC_TP53:28274,
LiGeA:CCLE_146,
LINCS_LDP:LCL-1347,
PharmacoDB:42MGBA_16_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1798,
Wikidata:Q54603004 |
|
|
CVCL_1798 |
2026-09-05 11:43:23 |
1 |
537-mel
Resource Report
Resource Website
|
RRID:CVCL_8052
|
Homo sapiens (Human)
|
Melanoma
|
From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
|
PMID:8027550
PMID:8081556
PMID:9670966
PMID:10048982
PMID:10754339
PMID:15467732
PMID:25485619
PMID:25877200
PMID:26589293
PMID:36139163
|
Cancer cell line
|
Male |
537-MEL, 537 mel, 537 MEL, 537mel, 537MEL, 537, Mel537 |
|
|
EFO:EFO_0006357,
ArrayExpress:E-MTAB-2706,
BioSample:SAMN03471452,
CGH-DB:9298-4,
Cosmic:876685,
Cosmic:905212,
Cosmic:1507618,
Cosmic:2233664,
EGA:EGAS00001000610,
EGA:EGAS00001002554,
GEO:GSM274694,
PharmacoDB:537MEL_19_2019,
Wikidata:Q54603831 |
|
|
CVCL_8052 |
2026-09-05 11:43:31 |
0 |
59M
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2291
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: OCCP ovarian cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2653399
PMID:8795574
PMID:15677628
PMID:22460905
PMID:23415752
PMID:23839242
PMID:25230021
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27561551
PMID:28196595
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Female |
OAW59M, OAW 59M, 59 M |
|
|
CLO:CLO_0001428,
EFO:EFO_0006358,
CLDB:cl110,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:498,
BioSample:SAMN03472466,
BioSample:SAMN10988041,
cancercelllines:CVCL_2291,
Cell_Model_Passport:SIDM01528,
DepMap:ACH-000520,
ECACC:89081802,
EGA:EGAS00001000610,
GEO:GSM313717,
GEO:GSM887904,
GEO:GSM1291125,
GEO:GSM1374376,
IARC_TP53:28342,
LiGeA:CCLE_458,
PharmacoDB:59M_21_2019,
PRIDE:PXD003668,
Progenetix:CVCL_2291,
Wikidata:Q54604004 |
|
|
CVCL_2291 |
2026-09-05 11:43:32 |
3 |
23132/87
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-201, RRID:CVCL_1046
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8100658
PMID:11668190
PMID:20164919
PMID:20215515
PMID:22460905
PMID:24807215
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
23132-87, 2313287, St 23132, St23132, 23132 |
DSMZ |
ACC-201 |
CLO:CLO_0001202,
EFO:EFO_0006528,
CLDB:cl38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:822,
BioSample:SAMN03470944,
BioSample:SAMN03473375,
BioSample:SAMN10988573,
cancercelllines:CVCL_1046,
Cell_Model_Passport:SIDM00980,
ChEMBL-Cells:CHEMBL3308702,
ChEMBL-Targets:CHEMBL1075382,
Cosmic:910924,
Cosmic:1995324,
Cosmic:2484956,
Cosmic-CLP:910924,
DepMap:ACH-000948,
DSMZ:ACC-201,
DSMZCellDive:ACC-201,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:910924,
GEO:GSM827572,
GEO:GSM886838,
GEO:GSM887901,
GEO:GSM1374371,
GEO:GSM1374372,
GEO:GSM1669566,
IARC_TP53:21150,
LiGeA:CCLE_415,
LINCS_LDP:LCL-1532,
PharmacoDB:2313287_13_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1046,
PubChem_Cell_line:CVCL_1046,
Wikidata:Q54583395 |
|
|
CVCL_1046 |
2026-09-05 11:42:54 |
2 |
253J
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_7935
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:66978
PMID:327080
PMID:571047
PMID:748774
PMID:944089
PMID:3518877
PMID:3708594
PMID:4431054
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7658585
PMID:8873383
PMID:11207054
PMID:11416159
PMID:11921286
PMID:12127398
PMID:15846775
PMID:16885334
PMID:23401075
PMID:24035680
PMID:24367658
PMID:25997541
PMID:26589293
PMID:26621286
PMID:27270441
PMID:29732388
PMID:31068700
|
Cancer cell line
|
Male |
253j, 253-J, 253 J, 253J-P, 253J-Parental, 253J P, 253JP |
|
|
BTO:BTO_0004796,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-108,
BioSample:SAMN10987961,
cancercelllines:CVCL_7935,
Cell_Model_Passport:SIDM01529,
Cosmic:715794,
Cosmic:760476,
Cosmic:845564,
Cosmic:925827,
Cosmic:928820,
Cosmic:1016884,
Cosmic:1046680,
Cosmic:1082644,
Cosmic:1285102,
Cosmic:1285997,
Cosmic:1927305,
Cosmic:1938694,
Cosmic:2050426,
Cosmic:2057433,
Cosmic:2444255,
Cosmic:2685929,
Cosmic:2700994,
DepMap:ACH-000011,
GEO:GSM136240,
GEO:GSM1574546,
GEO:GSM1574574,
IARC_TP53:21034,
KCLB:80001,
LiGeA:CCLE_259,
PharmacoDB:253J_14_2019,
Wikidata:Q54583653 |
|
|
CVCL_7935 |
2026-09-05 11:42:56 |
5 |
253J
Resource Report
Resource Website
1+ mentions
Discontinued
|
KCLB Cat# 80001, RRID:CVCL_7935
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:66978
PMID:327080
PMID:571047
PMID:748774
PMID:944089
PMID:3518877
PMID:3708594
PMID:4431054
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7658585
PMID:8873383
PMID:11207054
PMID:11416159
PMID:11921286
PMID:12127398
PMID:15846775
PMID:16885334
PMID:23401075
PMID:24035680
PMID:24367658
PMID:25997541
PMID:26589293
PMID:26621286
PMID:27270441
PMID:29732388
PMID:31068700
|
Cancer cell line
|
Male |
253j, 253-J, 253 J, 253J-P, 253J-Parental, 253J P, 253JP |
KCLB |
80001 |
BTO:BTO_0004796,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-108,
BioSample:SAMN10987961,
cancercelllines:CVCL_7935,
Cell_Model_Passport:SIDM01529,
Cosmic:715794,
Cosmic:760476,
Cosmic:845564,
Cosmic:925827,
Cosmic:928820,
Cosmic:1016884,
Cosmic:1046680,
Cosmic:1082644,
Cosmic:1285102,
Cosmic:1285997,
Cosmic:1927305,
Cosmic:1938694,
Cosmic:2050426,
Cosmic:2057433,
Cosmic:2444255,
Cosmic:2685929,
Cosmic:2700994,
DepMap:ACH-000011,
GEO:GSM136240,
GEO:GSM1574546,
GEO:GSM1574574,
IARC_TP53:21034,
KCLB:80001,
LiGeA:CCLE_259,
PharmacoDB:253J_14_2019,
Wikidata:Q54583653 |
|
|
CVCL_7935 |
2026-09-05 11:42:56 |
5 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
Hysigen Cat# TCH-C193, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
Hysigen |
TCH-C193 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-05 11:52:49 |
39236 |
CADO-ES1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1103
|
Homo sapiens (Human)
|
Ewing sarcoma
|
Caution: Was incorrectly indicated to have an EWSR1-FLI1 (EWS-FLI1) gene fusion in PubMed=23637631., Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1756482
PMID:11668190
PMID:19787792
PMID:20164919
PMID:21822310
PMID:22142829
PMID:22460905
PMID:23637631
PMID:25984343
PMID:26428435
PMID:26589293
PMID:27397505
PMID:29464090
PMID:30563222
PMID:30879952
PMID:30894373
PMID:31068700
PMID:33460449
PMID:35839778
|
Cancer cell line
|
Female |
CADO-ES-1, Cado-ES-1, CADO ES1, CADOES1, CADO-ES, Cado-ES, ESCADO1, Center for Adult Diseases Osaka-Ewing Sarcoma 1 |
|
|
CLO:CLO_0002173,
EFO:EFO_0002818,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-6067,
ArrayExpress:E-MTAB-6111,
BioGRID_ORCS_Cell_line:164,
BioSample:SAMN03473333,
BioSample:SAMN10988559,
cancercelllines:CVCL_1103,
Cell_Model_Passport:SIDM00961,
CLS:300127,
Cosmic:753539,
Cosmic:1718434,
Cosmic:2294581,
Cosmic-CLP:753539,
DepMap:ACH-000210,
DSMZ:ACC-255,
DSMZCellDive:ACC-255,
EGA:EGAS00001000978,
GDSC:753539,
GEO:GSM510004,
GEO:GSM886901,
GEO:GSM887966,
GEO:GSM1669643,
IARC_TP53:21207,
LiGeA:CCLE_114,
PharmacoDB:CADOES1_162_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1103,
Wikidata:Q54808333 |
|
|
CVCL_1103 |
2026-09-05 10:45:09 |
3 |
Caco-2
Resource Report
Resource Website
5000+ mentions
|
RRID:CVCL_0025
|
Homo sapiens (Human)
|
Colon adenocarcinoma
|
Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257; PubMed=34339474)., Virology: Highly susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=15316659; PubMed=15731278)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ENCODE project common cell types; tier 3., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AstraZeneca Colorectal cell line (AZCL) panel.
|
PMID:327080
PMID:833871
PMID:2914637
PMID:3349466
PMID:3518877
PMID:6935474
PMID:7459858
PMID:7764660
PMID:8253353
PMID:8508948
PMID:9294210
PMID:10092214
PMID:10612807
PMID:10737795
PMID:11414198
PMID:11416159
PMID:11668190
PMID:12584437
PMID:14599474
PMID:15316659
PMID:15731278
PMID:15868485
PMID:16418264
PMID:16854228
PMID:16957166
PMID:18258742
PMID:20570890
PMID:20606684
PMID:20831567
PMID:21607810
PMID:23272949
PMID:23932154
PMID:24042735
PMID:24755471
PMID:25485619
PMID:25841592
PMID:25877200
PMID:25926053
PMID:25944804
PMID:25960936
PMID:26537799
PMID:26589293
PMID:26869432
PMID:28196595
PMID:28683746
PMID:29101300
PMID:29787057
PMID:30894373
PMID:31068700
PMID:31981602
PMID:33389257
PMID:34339474
|
Cancer cell line
|
Male |
CaCo-2, CACO-2, Caco 2, CACO 2, CACO2, CaCo2, CaCO2, Caco2, Caco-2/ATCC, Caco-II |
|
|
BTO:BTO_0000195,
CLO:CLO_0002172,
CLO:CLO_0050627,
EFO:EFO_0001099,
MCCL:MCC:0000120,
CLDB:cl614,
CLDB:cl615,
CLDB:cl616,
CLDB:cl617,
CLDB:cl618,
CLDB:cl619,
CLDB:cl621,
CLDB:cl5174,
Abcam:ab275464,
AddexBio:C0009009/29,
ArrayExpress:E-MTAB-2706,
ATCC:HTB-37,
BCRJ:0059,
BioSample:SAMN03473140,
BioSample:SAMN05292461,
BioSample:SAMN10989600,
cancercelllines:CVCL_0025,
CCRID:1101HUM-PUMC000100,
CCRID:1102HUM-NIFDC00087,
CCRID:3101HUMSCSP5027,
CCRID:3101HUMTCHu146,
CCRID:4201HUM-CCTCC00153,
CCRID:5301HUM-KCB07010YJ,
CCTCC:GDC0153,
Cell_Model_Passport:SIDM00891,
ChEMBL-Cells:CHEMBL3307519,
ChEMBL-Targets:CHEMBL614058,
CLS:300137,
ColonAtlas:CACO2,
Cosmic:720340,
Cosmic:873696,
Cosmic:875297,
Cosmic:876709,
Cosmic:887244,
Cosmic:889531,
Cosmic:948127,
Cosmic:948829,
Cosmic:983736,
Cosmic:995392,
Cosmic:1043805,
Cosmic:1122320,
Cosmic:1132564,
Cosmic:1132694,
Cosmic:1184081,
Cosmic:1187299,
Cosmic:1310931,
Cosmic:1466811,
Cosmic:1479620,
Cosmic:1524334,
Cosmic:1552180,
Cosmic:1676742,
Cosmic:1708415,
Cosmic:1803940,
Cosmic:1933015,
Cosmic:2036652,
Cosmic:2145574,
Cosmic:2156940,
Cosmic:2301543,
Cosmic:2301964,
Cosmic:2667879,
Cosmic:2800568,
DepMap:ACH-000003,
DSMZ:ACC-169,
DSMZCellDive:ACC-169,
ECACC:09042001,
ECACC:86010202,
EGA:EGAS00001000610,
EGA:EGAS00001002554,
ENCODE:ENCBS311PHE,
ENCODE:ENCBS390JMI,
ENCODE:ENCBS391ENC,
ENCODE:ENCBS530YXL,
ENCODE:ENCBS700RKG,
ENCODE:ENCBS890JZY,
FANTOM5_SSTAR:10513-107D9,
FCS-free:192-2-378-1-3-3,
GEO:GSM206450,
GEO:GSM274711,
GEO:GSM274712,
GEO:GSM274725,
GEO:GSM383861,
GEO:GSM472900,
GEO:GSM472933,
GEO:GSM513908,
GEO:GSM514182,
GEO:GSM741244,
GEO:GSM749689,
GEO:GSM749691,
GEO:GSM749748,
GEO:GSM784006,
GEO:GSM843481,
GEO:GSM843482,
GEO:GSM845394,
GEO:GSM945162,
GEO:GSM945203,
GEO:GSM945206,
GEO:GSM945236,
GEO:GSM1006210,
GEO:GSM1006211,
GEO:GSM1006212,
GEO:GSM1346866,
GEO:GSM1374426,
GEO:GSM1448160,
GEO:GSM2549989,
GEO:GSM7701359,
GEO:GSM7701360,
IARC_TP53:21749,
IBRC:C10094,
ICLC:HTL97023,
IZSLER:BS TCL 87,
KCB:KCB 200710YJ,
KCLB:30037.1,
LINCS_LDP:LCL-1170,
Lonza:36,
MeSH:D018938,
MetaboLights:MTBLS227,
MetaboLights:MTBLS328,
NCBI_Iran:C139,
PharmacoDB:Caco2_161_2019,
PRIDE:PXD001550,
PRIDE:PXD005354,
PRIDE:PXD005355,
PRIDE:PXD018357,
PRIDE:PXD019645,
PRIDE:PXD023760,
Progenetix:CVCL_0025,
PubChem_Cell_line:CVCL_0025,
RCB:RCB0988,
TOKU-E:762,
Ubigene:YC-D003,
Wikidata:Q5016050 |
|
|
CVCL_0025 |
2026-09-05 10:45:09 |
9197 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
ATCC Cat# HTB-47, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080
PMID:571047
PMID:833871
PMID:3518877
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7591954
PMID:10723130
PMID:10929426
PMID:15585611
PMID:17409424
PMID:20215515
PMID:22185343
PMID:22460905
PMID:22949125
PMID:25485619
PMID:25877200
PMID:26589293
PMID:26972028
PMID:27141528
PMID:27993170
PMID:28196595
PMID:28489074
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
ATCC |
HTB-47 |
BTO:BTO_0006204,
CLO:CLO_0002177,
EFO:EFO_0002150,
MCCL:MCC:0000124,
CLDB:cl625,
CLDB:cl626,
CLDB:cl627,
CLDB:cl629,
4DN:4DNSRDD5W2FZ,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-47,
BCRJ:0408,
BioGRID_ORCS_Cell_line:583,
BioSample:SAMN01821542,
BioSample:SAMN01821619,
BioSample:SAMN03471873,
BioSample:SAMN10988361,
cancercelllines:CVCL_0235,
CancerTools:161904,
CCRID:1101HUM-PUMC000337,
Cell_Model_Passport:SIDM01546,
ChEMBL-Cells:CHEMBL3308071,
ChEMBL-Targets:CHEMBL613852,
CLS:300140,
Cosmic:687941,
Cosmic:874612,
Cosmic:877458,
Cosmic:979706,
Cosmic:982278,
Cosmic:1152536,
Cosmic:2520633,
DepMap:ACH-000234,
DSMZ:ACC-54,
DSMZCellDive:ACC-54,
ECACC:93120819,
EGA:EGAS00001000610,
ENCODE:ENCBS074UKQ,
ENCODE:ENCBS461KDA,
ENCODE:ENCBS611WID,
ENCODE:ENCBS768KGZ,
ENCODE:ENCBS787YGO,
GEO:GSM374478,
GEO:GSM886903,
GEO:GSM887968,
IARC_TP53:30022,
ICLC:HTL95029,
IGRhCellID:Caki2,
IZSLER:BS TCL 8,
KCLB:30047,
LiGeA:CCLE_157,
PharmacoDB:Caki2_164_2019,
PRIDE:PXD000335,
PRIDE:PXD003105,
Progenetix:CVCL_0235,
PubChem_Cell_line:CVCL_0235,
Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-09-05 10:45:12 |
278 |
CAL-120
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1104
|
Homo sapiens (Human)
|
Breast carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919
PMID:20215515
PMID:22460905
PMID:24176112
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30613774
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Female |
CAL 120, CAL120 |
|
|
CLO:CLO_0002179,
EFO:EFO_0005356,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-6647,
BioGRID_ORCS_Cell_line:166,
BioSample:SAMN03472991,
BioSample:SAMN03473555,
BioSample:SAMN10989564,
cancercelllines:CVCL_1104,
Cell_Model_Passport:SIDM00940,
ChEMBL-Cells:CHEMBL3308577,
ChEMBL-Targets:CHEMBL1075405,
Cosmic:906826,
Cosmic:1995355,
Cosmic:2164984,
Cosmic-CLP:906826,
DepMap:ACH-000212,
DSMZ:ACC-459,
DSMZCellDive:ACC-459,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:906826,
GEO:GSM274647,
GEO:GSM274665,
GEO:GSM344361,
GEO:GSM344411,
GEO:GSM783963,
GEO:GSM827160,
GEO:GSM843483,
GEO:GSM847210,
GEO:GSM847455,
GEO:GSM886904,
GEO:GSM887969,
GEO:GSM1172944,
GEO:GSM1669645,
IARC_TP53:21208,
LiGeA:CCLE_802,
LINCS_HMS:51110,
LINCS_LDP:LCL-1463,
PharmacoDB:CAL120_165_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1104,
PubChem_Cell_line:CVCL_1104,
SLKBase:3487,
Wikidata:Q54808384 |
|
|
CVCL_1104 |
2026-09-05 10:45:13 |
20 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
ICLC Cat# HTL95029, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080
PMID:571047
PMID:833871
PMID:3518877
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7591954
PMID:10723130
PMID:10929426
PMID:15585611
PMID:17409424
PMID:20215515
PMID:22185343
PMID:22460905
PMID:22949125
PMID:25485619
PMID:25877200
PMID:26589293
PMID:26972028
PMID:27141528
PMID:27993170
PMID:28196595
PMID:28489074
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
ICLC |
HTL95029 |
BTO:BTO_0006204,
CLO:CLO_0002177,
EFO:EFO_0002150,
MCCL:MCC:0000124,
CLDB:cl625,
CLDB:cl626,
CLDB:cl627,
CLDB:cl629,
4DN:4DNSRDD5W2FZ,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-47,
BCRJ:0408,
BioGRID_ORCS_Cell_line:583,
BioSample:SAMN01821542,
BioSample:SAMN01821619,
BioSample:SAMN03471873,
BioSample:SAMN10988361,
cancercelllines:CVCL_0235,
CancerTools:161904,
CCRID:1101HUM-PUMC000337,
Cell_Model_Passport:SIDM01546,
ChEMBL-Cells:CHEMBL3308071,
ChEMBL-Targets:CHEMBL613852,
CLS:300140,
Cosmic:687941,
Cosmic:874612,
Cosmic:877458,
Cosmic:979706,
Cosmic:982278,
Cosmic:1152536,
Cosmic:2520633,
DepMap:ACH-000234,
DSMZ:ACC-54,
DSMZCellDive:ACC-54,
ECACC:93120819,
EGA:EGAS00001000610,
ENCODE:ENCBS074UKQ,
ENCODE:ENCBS461KDA,
ENCODE:ENCBS611WID,
ENCODE:ENCBS768KGZ,
ENCODE:ENCBS787YGO,
GEO:GSM374478,
GEO:GSM886903,
GEO:GSM887968,
IARC_TP53:30022,
ICLC:HTL95029,
IGRhCellID:Caki2,
IZSLER:BS TCL 8,
KCLB:30047,
LiGeA:CCLE_157,
PharmacoDB:Caki2_164_2019,
PRIDE:PXD000335,
PRIDE:PXD003105,
Progenetix:CVCL_0235,
PubChem_Cell_line:CVCL_0235,
Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-09-05 10:45:12 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
DSMZ Cat# ACC-54, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080
PMID:571047
PMID:833871
PMID:3518877
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7591954
PMID:10723130
PMID:10929426
PMID:15585611
PMID:17409424
PMID:20215515
PMID:22185343
PMID:22460905
PMID:22949125
PMID:25485619
PMID:25877200
PMID:26589293
PMID:26972028
PMID:27141528
PMID:27993170
PMID:28196595
PMID:28489074
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
DSMZ |
ACC-54 |
BTO:BTO_0006204,
CLO:CLO_0002177,
EFO:EFO_0002150,
MCCL:MCC:0000124,
CLDB:cl625,
CLDB:cl626,
CLDB:cl627,
CLDB:cl629,
4DN:4DNSRDD5W2FZ,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-47,
BCRJ:0408,
BioGRID_ORCS_Cell_line:583,
BioSample:SAMN01821542,
BioSample:SAMN01821619,
BioSample:SAMN03471873,
BioSample:SAMN10988361,
cancercelllines:CVCL_0235,
CancerTools:161904,
CCRID:1101HUM-PUMC000337,
Cell_Model_Passport:SIDM01546,
ChEMBL-Cells:CHEMBL3308071,
ChEMBL-Targets:CHEMBL613852,
CLS:300140,
Cosmic:687941,
Cosmic:874612,
Cosmic:877458,
Cosmic:979706,
Cosmic:982278,
Cosmic:1152536,
Cosmic:2520633,
DepMap:ACH-000234,
DSMZ:ACC-54,
DSMZCellDive:ACC-54,
ECACC:93120819,
EGA:EGAS00001000610,
ENCODE:ENCBS074UKQ,
ENCODE:ENCBS461KDA,
ENCODE:ENCBS611WID,
ENCODE:ENCBS768KGZ,
ENCODE:ENCBS787YGO,
GEO:GSM374478,
GEO:GSM886903,
GEO:GSM887968,
IARC_TP53:30022,
ICLC:HTL95029,
IGRhCellID:Caki2,
IZSLER:BS TCL 8,
KCLB:30047,
LiGeA:CCLE_157,
PharmacoDB:Caki2_164_2019,
PRIDE:PXD000335,
PRIDE:PXD003105,
Progenetix:CVCL_0235,
PubChem_Cell_line:CVCL_0235,
Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-09-05 10:45:12 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
BCRJ Cat# 0408, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080
PMID:571047
PMID:833871
PMID:3518877
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7591954
PMID:10723130
PMID:10929426
PMID:15585611
PMID:17409424
PMID:20215515
PMID:22185343
PMID:22460905
PMID:22949125
PMID:25485619
PMID:25877200
PMID:26589293
PMID:26972028
PMID:27141528
PMID:27993170
PMID:28196595
PMID:28489074
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
BCRJ |
0408 |
BTO:BTO_0006204,
CLO:CLO_0002177,
EFO:EFO_0002150,
MCCL:MCC:0000124,
CLDB:cl625,
CLDB:cl626,
CLDB:cl627,
CLDB:cl629,
4DN:4DNSRDD5W2FZ,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-47,
BCRJ:0408,
BioGRID_ORCS_Cell_line:583,
BioSample:SAMN01821542,
BioSample:SAMN01821619,
BioSample:SAMN03471873,
BioSample:SAMN10988361,
cancercelllines:CVCL_0235,
CancerTools:161904,
CCRID:1101HUM-PUMC000337,
Cell_Model_Passport:SIDM01546,
ChEMBL-Cells:CHEMBL3308071,
ChEMBL-Targets:CHEMBL613852,
CLS:300140,
Cosmic:687941,
Cosmic:874612,
Cosmic:877458,
Cosmic:979706,
Cosmic:982278,
Cosmic:1152536,
Cosmic:2520633,
DepMap:ACH-000234,
DSMZ:ACC-54,
DSMZCellDive:ACC-54,
ECACC:93120819,
EGA:EGAS00001000610,
ENCODE:ENCBS074UKQ,
ENCODE:ENCBS461KDA,
ENCODE:ENCBS611WID,
ENCODE:ENCBS768KGZ,
ENCODE:ENCBS787YGO,
GEO:GSM374478,
GEO:GSM886903,
GEO:GSM887968,
IARC_TP53:30022,
ICLC:HTL95029,
IGRhCellID:Caki2,
IZSLER:BS TCL 8,
KCLB:30047,
LiGeA:CCLE_157,
PharmacoDB:Caki2_164_2019,
PRIDE:PXD000335,
PRIDE:PXD003105,
Progenetix:CVCL_0235,
PubChem_Cell_line:CVCL_0235,
Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-09-05 10:45:12 |
278 |
CAL-12T
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1105
|
Homo sapiens (Human)
|
Lung non-small cell carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1657424
PMID:2145926
PMID:2440566
PMID:18083107
PMID:20164919
PMID:20215515
PMID:22460905
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:29681454
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
Cal-12T, Cal.12T, CAL 12T, CAL12T, Cal12T, CAL 12, Centre Antoine Lacassagne-12T |
|
|
CLO:CLO_0002180,
EFO:EFO_0006547,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473097,
BioSample:SAMN10987846,
cancercelllines:CVCL_1105,
Cell_Model_Passport:SIDM00939,
ChEMBL-Cells:CHEMBL3308132,
ChEMBL-Targets:CHEMBL1075406,
Cosmic:753540,
Cosmic:1995356,
Cosmic-CLP:753540,
DepMap:ACH-000826,
DSMZ:ACC-443,
DSMZCellDive:ACC-443,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:753540,
GEO:GSM784241,
GEO:GSM827248,
GEO:GSM886905,
GEO:GSM887970,
GEO:GSM1669646,
IARC_TP53:21209,
LiGeA:CCLE_097,
LINCS_LDP:LCL-1603,
PharmacoDB:CAL12T_166_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1105,
PubChem_Cell_line:CVCL_1105,
Wikidata:Q54808385 |
|
|
CVCL_1105 |
2026-09-05 10:45:13 |
2 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
KCLB Cat# 30047, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080
PMID:571047
PMID:833871
PMID:3518877
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7591954
PMID:10723130
PMID:10929426
PMID:15585611
PMID:17409424
PMID:20215515
PMID:22185343
PMID:22460905
PMID:22949125
PMID:25485619
PMID:25877200
PMID:26589293
PMID:26972028
PMID:27141528
PMID:27993170
PMID:28196595
PMID:28489074
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
KCLB |
30047 |
BTO:BTO_0006204,
CLO:CLO_0002177,
EFO:EFO_0002150,
MCCL:MCC:0000124,
CLDB:cl625,
CLDB:cl626,
CLDB:cl627,
CLDB:cl629,
4DN:4DNSRDD5W2FZ,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-47,
BCRJ:0408,
BioGRID_ORCS_Cell_line:583,
BioSample:SAMN01821542,
BioSample:SAMN01821619,
BioSample:SAMN03471873,
BioSample:SAMN10988361,
cancercelllines:CVCL_0235,
CancerTools:161904,
CCRID:1101HUM-PUMC000337,
Cell_Model_Passport:SIDM01546,
ChEMBL-Cells:CHEMBL3308071,
ChEMBL-Targets:CHEMBL613852,
CLS:300140,
Cosmic:687941,
Cosmic:874612,
Cosmic:877458,
Cosmic:979706,
Cosmic:982278,
Cosmic:1152536,
Cosmic:2520633,
DepMap:ACH-000234,
DSMZ:ACC-54,
DSMZCellDive:ACC-54,
ECACC:93120819,
EGA:EGAS00001000610,
ENCODE:ENCBS074UKQ,
ENCODE:ENCBS461KDA,
ENCODE:ENCBS611WID,
ENCODE:ENCBS768KGZ,
ENCODE:ENCBS787YGO,
GEO:GSM374478,
GEO:GSM886903,
GEO:GSM887968,
IARC_TP53:30022,
ICLC:HTL95029,
IGRhCellID:Caki2,
IZSLER:BS TCL 8,
KCLB:30047,
LiGeA:CCLE_157,
PharmacoDB:Caki2_164_2019,
PRIDE:PXD000335,
PRIDE:PXD003105,
Progenetix:CVCL_0235,
PubChem_Cell_line:CVCL_0235,
Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-09-05 10:45:12 |
278 |
CAL-54
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-365, RRID:CVCL_1111
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8868943
PMID:20164919
PMID:20215515
PMID:22460905
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:28489074
PMID:30894373
PMID:31068700
PMID:31395879
PMID:35839778
|
Cancer cell line
|
Male |
CAL 54, CAL54, Centre Antoine Lacassagne-54 |
DSMZ |
ACC-365 |
CLO:CLO_0002186,
EFO:EFO_0002125,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473166,
BioSample:SAMN10988487,
cancercelllines:CVCL_1111,
Cell_Model_Passport:SIDM00932,
ChEMBL-Cells:CHEMBL3308346,
ChEMBL-Targets:CHEMBL1075412,
Cosmic:910952,
Cosmic-CLP:910952,
DepMap:ACH-000457,
DSMZ:ACC-365,
DSMZCellDive:ACC-365,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:910952,
GEO:GSM886910,
GEO:GSM887976,
GEO:GSM1669653,
IARC_TP53:21212,
IGRhCellID:CAL54,
LiGeA:CCLE_129,
LINCS_LDP:LCL-1757,
PharmacoDB:CAL54_173_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1111,
PubChem_Cell_line:CVCL_1111,
Wikidata:Q54808409 |
|
|
CVCL_1111 |
2026-09-05 10:45:13 |
1 |
Calu-6
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0236
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1855224
PMID:2388294
PMID:3129183
PMID:3335022
PMID:3518877
PMID:3940644
PMID:6148444
PMID:6935474
PMID:7459858
PMID:7834619
PMID:7972006
PMID:8385084
PMID:12068308
PMID:12794755
PMID:20164919
PMID:20215515
PMID:20679594
PMID:22460905
PMID:22961666
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:28196595
PMID:28273808
PMID:29681454
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Female |
CaLu-6, CALU-6, Calu.6, Calu 6, Calu6, CALU6, CaLu-06 |
|
|
BTO:BTO_0002235,
CLO:CLO_0002193,
EFO:EFO_0002152,
MCCL:MCC:0000125,
CLDB:cl636,
CLDB:cl638,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-56,
BioGRID_ORCS_Cell_line:587,
BioSample:SAMN03473148,
BioSample:SAMN10987791,
cancercelllines:CVCL_0236,
CancerTools:161924,
CCRID:1101HUM-PUMC000813,
CCRID:3101HUMTCHu144,
Cell_Model_Passport:SIDM00921,
ChEMBL-Cells:CHEMBL3307639,
ChEMBL-Targets:CHEMBL614535,
CLS:300135,
Cosmic:724859,
Cosmic:929969,
Cosmic:933575,
Cosmic:934466,
Cosmic:934542,
Cosmic:1071885,
Cosmic:1089230,
Cosmic:1146874,
Cosmic:1176611,
Cosmic:1434959,
Cosmic:1995360,
Cosmic:2668262,
Cosmic-CLP:724859,
DepMap:ACH-000264,
DSMZ:ACC-734,
DSMZCellDive:ACC-734,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:724859,
GEO:GSM108805,
GEO:GSM108806,
GEO:GSM253341,
GEO:GSM434325,
GEO:GSM513938,
GEO:GSM514319,
GEO:GSM794263,
GEO:GSM817065,
GEO:GSM843487,
GEO:GSM886916,
GEO:GSM887982,
GEO:GSM1374435,
GEO:GSM1374436,
GEO:GSM1669659,
IARC_TP53:119,
IARC_TP53:21265,
ICLC:HTL97003,
IGRhCellID:Calu6,
KCLB:30056,
LiGeA:CCLE_215,
LINCS_LDP:LCL-1626,
Lonza:1139,
NCBI_Iran:C431,
PharmacoDB:Calu6_180_2019,
PRIDE:PXD025499,
PRIDE:PXD030304,
Progenetix:CVCL_0236,
PubChem_Cell_line:CVCL_0236,
Wikidata:Q54808427 |
|
|
CVCL_0236 |
2026-09-05 10:45:14 |
35 |
CAL-29
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1808
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2440566
PMID:11720483
PMID:20215515
PMID:22460905
PMID:24035680
PMID:24367658
PMID:26589293
PMID:27397505
PMID:29732388
PMID:30894373
PMID:31068700
PMID:31395879
PMID:35839778
|
Cancer cell line
|
Female |
CAL 29, CAL29, Centre Antoine Lacassagne-29 |
|
|
CLO:CLO_0037157,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:584,
BioSample:SAMN03473515,
BioSample:SAMN10988514,
cancercelllines:CVCL_1808,
Cell_Model_Passport:SIDM00936,
Cosmic:1285115,
Cosmic:1995357,
Cosmic:2050440,
Cosmic:2057444,
Cosmic:2444248,
Cosmic:2685941,
Cosmic-CLP:1290730,
DepMap:ACH-000142,
DSMZ:ACC-515,
DSMZCellDive:ACC-515,
EGA:EGAS00001000978,
GDSC:1290730,
GEO:GSM827161,
GEO:GSM886908,
GEO:GSM887973,
GEO:GSM1669649,
IARC_TP53:28275,
LiGeA:CCLE_765,
LINCS_LDP:LCL-1711,
PharmacoDB:CAL29_169_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1808,
Wikidata:Q54808396 |
|
|
CVCL_1808 |
2026-09-05 10:45:13 |
4 |
